Anti B7-H3/4-1BB bispecific antibody(Innolake Biopharm)

N/A

Report date: 2026/04/24 20:01:59

Base Information

Drug NameAnti B7-H3/4-1BB bispecific antibody(Innolake Biopharm)
Drug Alias NameN/A
ClassificationBiologics > Protein drugs > Immunoglobulin > Antibody > Monoclonal antibody > Multispecific monoclonal antibody > Bispecific monoclonal antibody
Mechanisms of ActionAnti-CD276Anti-Tumor necrosis factor receptor superfamily member 9
TargetsCD276 antigenTumor necrosis factor receptor superfamily member 9
Therapy Area/IndicationsAutoimmune DiseasesNeoplasms
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryMainland China
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaPreclinical
Originator CompaniesInnolake Biopharm (Hangzhou) Co Ltd
China Registration ClassN/A

Develop Information

Active CompaniesInnolake Biopharm (Hangzhou) Co Ltd
Inactive CompaniesN/A
Active IndicationsAutoimmune DiseasesNeoplasms
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A